Nyumbani › Meningioma
Majaribio ya kliniki ya Meningioma yanayovutia washiriki nchini Marekani
Masomo 28 ya Meningioma yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- New York City, NYUtafiti 8
- Miami, FLUtafiti 7
- Boston, MAUtafiti 6
- Columbus, OHUtafiti 6
- San Francisco, CAUtafiti 5
- San Diego, CAUtafiti 5
- Atlanta, GAUtafiti 5
- Jacksonville, FLUtafiti 5
- Houston, TXUtafiti 4
- Arlington, VAUtafiti 4
- Phoenix, AZUtafiti 4
- Detroit, MIUtafiti 4
- St. Louis, MOUtafiti 3
- Durham, NCUtafiti 3
- Omaha, NEUtafiti 3
- Baltimore, MDUtafiti 3
- Tampa, FLUtafiti 3
- Milwaukee, WIUtafiti 3
- Cincinnati, OHUtafiti 3
- Los Angeles, CAUtafiti 3
- Seattle, WAUtafiti 3
- Cedar Rapids, IAUtafiti 3
- Nashville, TNUtafiti 3
Kwa jimbo
- ArizonaUtafiti 4
- CaliforniaUtafiti 12
- FloridaUtafiti 7
- GeorgiaUtafiti 5
- IndianaUtafiti 3
- IowaUtafiti 3
- KentuckyUtafiti 3
- MarylandUtafiti 5
- MassachusettsUtafiti 6
- MichiganUtafiti 4
- MinnesotaUtafiti 4
- MissouriUtafiti 3
- NebraskaUtafiti 3
- New HampshireUtafiti 3
- New YorkUtafiti 9
- North CarolinaUtafiti 5
- OhioUtafiti 7
- PennsylvaniaUtafiti 3
- TennesseeUtafiti 4
- TexasUtafiti 4
- VirginiaUtafiti 4
- WashingtonUtafiti 3
- WisconsinUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06955169Natural History Study of Patients With Neurofibromatosis Type 2
InaajiriUtafiti wa uchunguzi
Umri 8 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT00598351UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT04343157A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
InaajiriHatua 2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT04374305Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT06557512Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT06014905RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Ago 2026 · NCT07150806A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Jul 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT04427384Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
InaajiriHatua 1/2
Umri 4 hadi 39 · Jinsia zote · Imesasishwa 20 Jul 2026 · NCT05278208Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
InaajiriHatua ya kwanza ya awali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Jun 2026 · NCT07493447Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 10 Jun 2026 · NCT05576103Cognitive Status After Removal of Skull Base Meningioma
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 89 · Jinsia zote · Imesasishwa 22 Mei 2026 · NCT04635657Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 19 Mei 2026 · NCT07418775Cabozantinib for Patients With Recurrent or Progressive Meningioma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Mei 2026 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
InaajiriHatua 1/2
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 14 Mei 2026 · NCT05636618Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Apr 2026 · NCT04082520Abemaciclib in Newly Diagnosed Meningioma Patients
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Mac 2026 · NCT05940493Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
InaajiriHatua 4
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 27 Feb 2026 · NCT06377371Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Feb 2026 · NCT04278118Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Feb 2026 · NCT06132685Evaluation of the CONVIVO System
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Feb 2026 · NCT05139277Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Feb 2026 · NCT06650163Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.